Published in Semin Neurol on September 05, 2014
Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair. Redox Biol (2015) 0.88
Dynamic DNA methylation in the brain: a new epigenetic mark for experience-dependent plasticity. Front Cell Neurosci (2015) 0.85
DNA methyltransferase 1 mutations and mitochondrial pathology: is mtDNA methylated? Front Genet (2015) 0.78
A novel MeCP2 acetylation site regulates interaction with ATRX and HDAC1. Genes Cancer (2015) 0.78
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 25.75
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet (2006) 18.08
Eukaryotic cytosine methyltransferases. Annu Rev Biochem (2005) 15.45
Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci (2006) 13.32
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet (2001) 9.82
Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet (2002) 9.16
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet (2001) 8.64
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
Perceptions of epigenetics. Nature (2007) 8.43
Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol (1998) 7.61
Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron (2006) 6.50
UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet (1997) 5.97
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell (1991) 4.90
An integrated epigenetic and genetic approach to common human disease. Trends Genet (2004) 4.89
MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron (2007) 4.15
Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol (2010) 4.03
Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet (2005) 3.87
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature (2011) 3.19
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet (2011) 3.16
Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet (2008) 3.06
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol (2009) 3.05
The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet (2007) 2.60
The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol (1999) 2.57
Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis (2005) 2.44
Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci (2013) 2.38
Genomic imprinting: employing and avoiding epigenetic processes. Genes Dev (2009) 2.26
DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma (2009) 2.13
Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J Neurosci (2003) 1.93
Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Hum Mol Genet (2009) 1.86
Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell (2013) 1.80
Clinical and genetic aspects of Angelman syndrome. Genet Med (2010) 1.74
Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci (2011) 1.72
Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet (2001) 1.71
Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol Dis (2009) 1.66
DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Mol Genet (2007) 1.65
Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet (2014) 1.58
Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol (2008) 1.53
Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol (2005) 1.52
Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet (2012) 1.48
Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development (2006) 1.44
Sequence-specific recognition of methylated DNA by human zinc-finger proteins. Nucleic Acids Res (2010) 1.41
The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. PLoS One (2010) 1.37
Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci. Eur J Hum Genet (2010) 1.37
Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet (2014) 1.34
Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology (2012) 1.33
Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis (2010) 1.33
Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet (2003) 1.29
Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst (2007) 1.29
Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure. Clin Genet (2008) 1.26
Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J Neurosci (2013) 1.26
Targeted methylation testing of a patient cohort broadens the epigenetic and clinical description of imprinting disorders. Am J Med Genet A (2013) 1.25
Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet (2011) 1.24
MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet (2005) 1.21
Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci (2003) 1.20
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet (2007) 1.20
Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities. Mol Psychiatry (2013) 1.12
Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects. Eur J Hum Genet (2004) 1.12
Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol (1999) 1.12
Genetic syndromes caused by mutations in epigenetic genes. Hum Genet (2013) 1.11
Methyl-CpG binding proteins in the nervous system. Cell Res (2005) 1.07
Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient. Epigenetics (2012) 1.05
ATRX: the case of a peculiar chromatin remodeler. Epigenetics (2012) 1.03
Extended spectrum of MBD5 mutations in neurodevelopmental disorders. Eur J Hum Genet (2013) 1.03
Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet (2013) 1.02
Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder. Eur J Hum Genet (2013) 1.02
Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol (1999) 1.01
Neurologic manifestations of Angelman syndrome. Pediatr Neurol (2013) 1.01
Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients. J Hum Genet (2013) 0.92
Maintenance of DNA methylation: Dnmt3b joins the dance. Epigenetics (2011) 0.92
The evolving epigenome. Hum Mol Genet (2013) 0.91
Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice. Anat Rec (Hoboken) (2011) 0.91
Disturbed methylation at multiple imprinted loci: an increasing observation in imprinting disorders. Epigenomics (2011) 0.91
A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations. J Dev Behav Pediatr (2010) 0.90
Insights into the role of DNA methylation in disease through the use of mouse models. Dis Model Mech (2010) 0.89
Clinical variability in Rett syndrome. J Child Neurol (2003) 0.89
Rett syndrome and MeCP2. Neuromolecular Med (2014) 0.87
Role of ART in imprinting disorders. Semin Reprod Med (2012) 0.87
Rett syndrome: from bed to bench. Pediatr Neonatol (2011) 0.87
Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states. Annu Rev Genomics Hum Genet (2014) 0.86
Understanding the pathogenesis of Angelman syndrome through animal models. Neural Plast (2012) 0.84
RNAs of the human chromosome 15q11-q13 imprinted region. Wiley Interdiscip Rev RNA (2012) 0.83
Human imprinting syndromes. Epigenomics (2009) 0.82
Revisiting epilepsy and the electroencephalogram patterns in Angelman syndrome. Neurol Sci (2014) 0.79
Lessons from two human chromatin diseases, ICF syndrome and Rett syndrome. Int J Biochem Cell Biol (2008) 0.79
MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients. Brain Dev (2006) 0.79
Early-onset encephalopathy and cortical myoclonus in a boy with MECP2 gene mutation. Neurology (2004) 0.79